17.6 C
New York
Wednesday, September 25, 2024

Maker of popular diabetes and weight-loss drugs grilled about high cost in the U.S.

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Biden, in final U.N. speech, says world is at an ‘inflection point’

    02:09

  • Surge in women’s basketball extends to neighborhood pickup games

    01:44

  • Now Playing

    Maker of popular diabetes and weight-loss drugs grilled about high cost in the U.S.

    02:23

  • UP NEXT

    Justice Department accuses Visa of monopolizing debit card transactions

    01:09

  • Hostage families speak about frustration, hope and emotional toll of ordeal

    04:28

  • Tropical Storm Helene expected to rapidly intensify into a major hurricane

    00:56

  • Israel bombards southern Lebanon and Beirut for a second day

    02:11

  • Former hostage: ‘I thought that I’m going to die all the time’

    01:19

  • Good News: Mom whose limbs were amputated gifted new home

    01:56

  • San Francisco cracks down on deepfake websites

    03:01

  • Trump makes Pennsylvania town latest focus on immigrants

    02:26

  • New details revealed in alleged Trump assassination plot

    01:43

  • Hundreds killed in Israeli airstrikes, Lebanese officials say

    02:14

  • Iran’s new vice president says Iran does not want a wider war

    01:38

  • New polls show shifting race nationally and in key battlegrounds

    02:01

  • High school football player surprises teammates with special gift

    02:30

  • Behind-the-scenes look at NFL’s facial authentication technology

    02:36

  • A behind-the-scenes look at security preps for the UN General Assembly

    02:29

  • Newly-released body camera footage shows an officer-involved shooting in the NYC subway

    01:34

  • Donald Trump campaigns in battleground North Carolina

    02:07

The CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes and weight-loss drugs. Lars Jorgensen said pharmacy benefit managers are mostly to blame. NBC News’ Stephanie Gosk reports.

Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles